Last filing: Jun 24, 2026. Most recent purchase on record: Dec 29, 2021.
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 0 of the 13 calendar months from Oct 2025 to Oct 2026.
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | Director | Aug 26, 2021 | Jun 24, 2026 |
| Amgen (AMGN) | Former Director | Aug 6, 2015 | May 7, 2020 |
| Merck & Co. (MRK) | Former Chairman and CEO, Director | Nov 28, 2003 | Nov 4, 2009 |
Also a director at
Amgen (AMGN) (no filing in the last 18 months), Merck & Co. (MRK) (no filing in the last 18 months)
Recent filings
The last day with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jun 22, 2026, BridgeBio Pharma, Inc.: 3,990 shares granted. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.